Is the effectiveness of Carragelose® clinically proven?

Yes. Multiple clinical trials involving nearly 600 adult and pediatric patients have demonstrated the safety and effectiveness of Carragelose® nasal sprays in the treatment of the common cold.

In addition, in vitro studies have shown a non-specific virus-trapping effect against a broad range of respiratory viruses, including SARS-CoV-2. While Carragelose® products cannot fully prevent viral infections, they may significantly reduce viral load and transmission risk.
Scientific publications are available upon request.